1-855-378-42281-855-378-4228
One of the outpatient treatment alternatives for individuals in Cobbtown struggling with opioid dependence and addiction is called opioid maintenance therapy. Licensed clinics and doctors are authorized to give specific meds to opioid addicted people, many of which are opioid-based themselves and are habit forming. With low amounts however, the client doesn't experience high feelings but also does not experience intense cravings and isn't experiencing opioid withdrawal. Methadone is the first medication tried for this sole purpose, but there are alternative options to choose from.
Methadone is an opiate and is meant to be taken at an out-patient medical center certified to administer the drug, which is taken on a daily basis as a pill or liquid. The cost of the drug is about $150 per month. Buprenorphine is also an opiate based drug, and is in pill form often taken one day on, one day off. But different from Methadone which is only be administered in structured clinics, Buprenorphine can be and is prescribed and administered in doctor's offices. The cost monthly of buprenorphine is around $300 a month for the generic version of the drug. There is also a version of buprenorphine that contains naloxone, that is a med which reverses the effects of opioids. An individual taking this version of the drug, also known as Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and costs about $450 /month. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other drugs mentioned it is an opiate blocker and isn't an opiate. There is an option to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, it prevents an individual from feeling high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 /month.
For All Alcohol and Drug Rehabilitation Facilities In Cobbtown, Click Here.
